Targeting system for cancer treatment
AssigneeCoretag IP B.V.
InventorMarkwin Hendrik MARING
Life of this patent
Estimating the term…
Abstract
The invention relates to a targeting system for cancer comprising a cancer treatment moiety, such as radioisotope, with improved therapeutic effect, the use thereof as a medicament, such as for cancers, to a dosage comprising the targeting system, the use thereof in therapy, and the use thereof in treatment, as well as to a method of forming a targeting system. In particular the invention relates to systems targeting cancer cells.
Claims19
A targeting system for cancer treatment comprising an albumin binding moiety (AB), attached to the albumin binding moiety a targeting molecule (TM), wherein the targeting molecule is a cyanine, and wherein the albumin binding moiety comprises an carboxylic acid residue moiety, the carboxylic acid moiety attached to a phenyl moiety, and attached to the phenyl moiety at least one first chemical moiety, wherein the at least one first chemical moiety is selected from F, phenyl, C, O, CF3, OCH3, NO2, NH2, CH3, Cl, OCF3, and combinations thereof, and attached to the targeting molecule a cancer treatment moiety.
Dependencies are inferred from the claim text.